316 related articles for article (PubMed ID: 27540701)
1. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation.
Lee KW; Suh SW; Choi Y; Jeong J; Yi NJ; Kim H; Yoon KC; Hong SK; Kim HS; Lee KB; Suh KS
Liver Transpl; 2017 Jan; 23(1):19-27. PubMed ID: 27540701
[TBL] [Abstract][Full Text] [Related]
2. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation.
Choi HJ; Kim DG; Na GH; Hong TH; Bae SH; You YK; Choi JY; Yoon SK
Liver Transpl; 2017 Aug; 23(8):1023-1031. PubMed ID: 28480517
[TBL] [Abstract][Full Text] [Related]
3. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
4. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
5. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein and
Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
[TBL] [Abstract][Full Text] [Related]
7. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
12. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
13. Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Gon H; Kido M; Tanaka M; Kinoshita H; Komatsu S; Tsugawa D; Awazu M; Toyama H; Matsumoto I; Itoh T; Fukumoto T
Surgery; 2018 Nov; 164(5):1014-1022. PubMed ID: 30093272
[TBL] [Abstract][Full Text] [Related]
14. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
[TBL] [Abstract][Full Text] [Related]
15. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
16. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.
Eguchi S; Takatsuki M; Hidaka M; Soyama A; Tomonaga T; Muraoka I; Kanematsu T
World J Surg; 2010 May; 34(5):1034-8. PubMed ID: 20127241
[TBL] [Abstract][Full Text] [Related]
17. New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.
Fukumoto T; Kido M; Takebe A; Tanaka M; Kinoshita H; Kuramitsu K; Komatsu S; Tsugawa D; Goto T; Asari S; Toyama H; Ajiki T; Ku Y
Surg Today; 2017 Sep; 47(9):1094-1103. PubMed ID: 28324163
[TBL] [Abstract][Full Text] [Related]
18. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
19. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.
Iguchi T; Shirabe K; Aishima S; Wang H; Fujita N; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Oda Y; Maehara Y
Transplantation; 2015 Jun; 99(6):1236-42. PubMed ID: 25427164
[TBL] [Abstract][Full Text] [Related]
20. The effect of hepatocellular carcinoma bile duct tumor thrombi in liver transplantation.
Kim JM; Kwon CH; Joh JW; Park JB; Gwak MS; Lee JH; Kim GS; Kim SJ; Lee SK
Hepatogastroenterology; 2014 Sep; 61(134):1673-6. PubMed ID: 25436361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
